The MoCA-S1-2 is a short, easy-to-use, and useful test for diagnosing aMCI and mild dementia.Įxisten pocas validaciones de la versión en español de la prueba Montreal Cognitive Assessment (MoCA-S) en Latinoamérica. The MoCA-S1-2 showed significantly greater discriminant validity than the MMSE for differentiating aMCI from dementia. The level of education had a great impact on scores: as a result, 2 points were added for patients with less than 8 years of schooling and one point for patients with 8-12 years of schooling (MoCA-S1-2). The optimal cut-off points for aMCI and mild dementia were < 21 and < 20, respectively, with sensitivity and specificity rates of 75% and 82% for aMCI and 90% and 86% for mild dementia. The MoCA-S was found to be an effective and valid test for detecting aMCI (AUC = 0.903) and mild dementia (AUC = 0.957) its effectiveness for detecting naMCI was lower (AUC = 0.629). 01), and high intra-rater reliability (test-retest reliability coefficient: 0.922 P <. The MoCA-S displayed good internal consistency (Cronbach’s α: 0.772), high inter-rater reliability (Spearman correlation coefficient: 0.846 P <. Mean age and years of schooling were 73 ± 6 and 11 ± 4 years, respectively, with no significant intergroup differences. Participants were evaluated with both the MoCA-S and the Mini-Mental State Examination (MMSE) to determine the discriminant validity of the MoCA-S. ![]() Methodsġ72 individuals were grouped according to their clinical diagnosis based on the Clinical Dementia Rating (CDR) scale as follows: amnestic mild cognitive impairment (aMCI n = 24), non-amnestic MCI (naMCI n = 24), mild dementia (n = 20), and cognitively normal (n = 104). To evaluate the psychometric properties and discriminant validity of the MoCA-S in elderly patients in Santiago de Chile. However, the average educational level was high in this study thus, caution should be exercised when extrapolating these results to individuals with lower educational levels.Few studies have validated the Spanish-language version of the Montreal Cognitive Assessment (MoCA-S) test in Latin American populations. The MoCA‐S is valid and adequate for application in Colombia with good internal consistency, inter‐observer reliability, and content validity. The MoCA‐S is a valid screening tool and is useful for identifying MCI and MD in Colombia. The percentage of patients clearly labeled by the MoCA‐S was 85%. Using a cutoff score of ≥23, the MoCA had sensitivities of 76.0% to detect MCI and 92.7% to detect MD and a specificity of 79.8%. The psychometric evaluation of the MoCA‐S was appropriate. The remaining 84 participants were healthy subjects from the community. ![]() A total of 193 subjects were evaluated, 109 of whom were patients, including 26 who met the mild cognitive impairment (MCI) clinical criteria, based on neuropsychological testing, and 83 who had mild dementia (MD). This study is the first validation in Latin America of the MoCA in Spanish (MoCA‐S), which was developed in Colombia (South America).Īiming to perform the first validation of the MoCA‐S, we developed a study of concordance by conformity to assess the MoCA‐S compared with diagnostic consensus by interdisciplinary assessment in the Memory Clinic (the best diagnostic method available) and to evaluate the psychometric properties of the MoCA‐S. The Montreal Cognitive Assessment (MoCA) was developed as a simple screening tool for cognitive impairment. T1 Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia T1 - Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |